216 related articles for article (PubMed ID: 34188686)
1. A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma.
Liu J; Lu J; Li W
Stem Cells Int; 2021; 2021():5546032. PubMed ID: 34188686
[TBL] [Abstract][Full Text] [Related]
2. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
3. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
Gao B; Wang Y; Lu S
Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
[TBL] [Abstract][Full Text] [Related]
4. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene-related signature associated with prognosis and therapy response.
Chen L; Zhang D; Zheng S; Li X; Gao P
Front Genet; 2022; 13():959834. PubMed ID: 36110210
[No Abstract] [Full Text] [Related]
5. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.
Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N
Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823
[No Abstract] [Full Text] [Related]
6. Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma.
Gao B; Wang Y; Li C; Lu S
Front Immunol; 2023; 14():1114717. PubMed ID: 36814910
[TBL] [Abstract][Full Text] [Related]
7. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
8. Identifying Prognostic Significance of RCL1 and Four-Gene Signature as Novel Potential Biomarkers in HCC Patients.
Liu J; Zhang SQ; Chen J; Li ZB; Chen JX; Lu QQ; Han YS; Dai W; Xie C; Li JC
J Oncol; 2021; 2021():5574150. PubMed ID: 34257652
[TBL] [Abstract][Full Text] [Related]
9. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma.
Zhang G; Zhang K; Zhao Y; Yang Q; Lv X
BMC Cancer; 2022 Oct; 22(1):1103. PubMed ID: 36307751
[TBL] [Abstract][Full Text] [Related]
10. A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma.
Xu H; Zou R; Liu J; Zhu L
J Oncol; 2021; 2021():6653247. PubMed ID: 33747079
[TBL] [Abstract][Full Text] [Related]
11. Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma.
Song ZB; Yu Y; Zhang GP; Li SQ
Front Cell Dev Biol; 2021; 9():728574. PubMed ID: 34676211
[TBL] [Abstract][Full Text] [Related]
12. Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma.
Li MT; Zheng KF; Qiu YE
World J Clin Oncol; 2024 Feb; 15(2):243-270. PubMed ID: 38455128
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
Wang Y; Wan X; Du S
Front Immunol; 2023; 14():1100100. PubMed ID: 37622118
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma.
Lin Z; Xu Q; Song X; Zeng Y; Zeng L; Zhao L; Xu J; Miao D; Chen Z; Yu F
Front Oncol; 2022; 12():748557. PubMed ID: 35311113
[TBL] [Abstract][Full Text] [Related]
15. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma.
Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J
Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941
[TBL] [Abstract][Full Text] [Related]
16. Glycolysis-Related Gene Signature Can Predict Survival and Immune Status of Hepatocellular Carcinoma.
Xu Q; Miao D; Song X; Chen Z; Zeng L; Zhao L; Xu J; Lin Z; Yu F
Ann Surg Oncol; 2022 Jun; 29(6):3963-3976. PubMed ID: 35266081
[TBL] [Abstract][Full Text] [Related]
17. Development and External Validation of a Novel Immune Checkpoint-Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma.
Zhao E; Chen S; Dang Y
Front Mol Biosci; 2020; 7():620765. PubMed ID: 33553243
[No Abstract] [Full Text] [Related]
18. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
19. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
20. A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma.
Huo J; Wu L; Zang Y
Front Mol Biosci; 2020; 7():581354. PubMed ID: 33282911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]